Abbott receives regulatory approval for FreeStyle Lite test strips

ALAMEDA, Calif. The Food and Drug Administration approved blood-glucose test strips from Abbott.

Abbott's new FreeStyle Lite test strips use an enzyme which is unaffected by common nonglucose sugars, such as maltose or galactose, and minimizes the potential for other interference, Abbott said. The strips also are compatible with the company's FreeStyle Lite blood-glucose monitoring systems.

"The new FreeStyle Lite test strips represent Abbott's latest  success in delivering innovative products for people living with  diabetes," said Heather Mason, SVP Abbott Diabetes Care. "Abbott is delivering on what patients and healthcare professionals demand in diabetes care, especially for people who use insulin to manage their diabetes."

FreeStyle Lite test strips will be available in July.